Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05022550 · ClinicalTrials.gov registry record · NA
Virtual-reality and Emotion Regulation in Violence-Exposed Youth
A NA study of Adolescent Behavior and Emotional Regulation, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT05022550: Completed NA study of Adolescent Behavior and Emotional Regulation, sponsored by University of Wisconsin, Madison.
NCT05022550 is a NA study of Adolescent Behavior and Emotional Regulation that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 74 participants, below the 328-participant average among 46 other Adolescent Behavior trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05022550, a NA study of Adolescent Behavior and Emotional Regulation, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
The current proposal aims to evaluate a novel virtual-reality-based (VR-B) video game treatment for emotional dysregulation for youth currently under the supervision of the juvenile justice system. 135 participants under the age of 17 will be enrolled and will be asked to complete up to 6 VR-B sessions.
Primary Outcome
Rated between neutral and strongly agree to the question: "I found the virtual environment to be engaging and enjoyable".
Conditions Studied
Interventions
- DEVICE DEEP VR
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2022-06-03 |
| Est. Completion | 2025-05-01 |
| Phase | NA |
What the finished NCT05022550 record still lists
NCT05022550 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 328-participant average among 46 other Adolescent Behavior trials with a reported enrollment target (77% lower).
The record links to 2 conditions, with Adolescent Behavior appearing as the primary indexed condition, and to 1 intervention - of which DEEP VR is the first listed.
NCT05022550 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05022550 about?
NCT05022550 is a clinical study titled "Virtual-reality and Emotion Regulation in Violence-Exposed Youth". The current proposal aims to evaluate a novel virtual-reality-based (VR-B) video game treatment for emotional dysregulation for youth currently under the supervision of the juvenile justice system. 135 participants under the age of 17 will be enrolled and will be asked to complete up to 6 VR-B sessi...
What is the current status of trial NCT05022550?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2022-06-03. Estimated completion is 2025-05-01.
What conditions does trial NCT05022550 study?
This clinical trial studies the following conditions: Adolescent Behavior, Emotional Regulation.
What interventions are being tested in trial NCT05022550?
The interventions under investigation include: DEEP VR (DEVICE).
Who is sponsoring clinical trial NCT05022550?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05022550 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adolescent Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05022550's enrollment target sits among peer trials
74 39th of 46 higher than 7 of 46 other Adolescent Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Adolescent Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
RECRUITING · NA
-
Clinical Trial for Integrated Care to Help At Risk Teen (iCHART) Intervention
RECRUITING · NA
-
Shifting Sleep Timing in Teens
RECRUITING · NA
-
Evaluation of Parent Toolkit 2.0 (Morehouse Family Health Study)
RECRUITING · NA
-
Students With Involved Families and Teachers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI